| http://www.w3.org/ns/prov#value | - CONTACT: Gerry Gould VP-Investor Relations Tel. (781) ... ... ... http://www.bio-medicine.org/inc/biomed/medicine-technology.asp http://feeds.bio-medicine.org/latest-medical-technologyDate:4/29/2012 l; transaction costs; actual or contingent liabilities; and other risks and uncertainties discussed in Haemonetics' filings with the U.S. Securities and Exchange Commission, including the Risk Factors
|
